Hepatitis C virus infection: Quality of life and side effects of treatment

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 250-254

  Foster, G R ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

HCV; Quality of life; Side effects

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ANEMIA; ANOREXIA; CHRONICITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; FLU LIKE SYNDROME; HEPATITIS C; HUMAN; LIVER INJURY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; WELLBEING;

EID: 0033406824     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80411-5     Document Type: Conference Paper

References (16)

1. WHO Consultation Group. Global surveillance and control of hepatitis C. J Viral Hep 1999: 6: 35-47.
2. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997: 309: 825-832.
3. Hadziyannis S. Non hepatic manifestations of chronic HCV infection. J Viral Hepat 1997: 4: 1-17.
4. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival. Tradeoffs between quality and quantity of life in laryngeal carcinoma. N Engl J Med 1981: 305: 982-987.
5. Bergner M, Bobbitt R, Carter W, Gilson W. The sickness impact profile: development and final revision of a health status measure. Med Care 1981: 19: 787-805.
6. Stewart A, Hays R, Ware J. Stewart A, Ware J, editors. Measuring functioning and well being: the medical outcomes study approach. Methods of validating the MOS health measures. London: Duke University Press: 1992.
7. Johnson M, Fisher D, Fenaughty A, Theno S. Hepatitis C and depression in drug users. Am J Gastroenterol 1998: 93: 785789.
8. Hunt C, Dominitz J, Bute B, Waters B, Blasi U, Williams D. Effect of interferon alpha treatment of chronic hepatitis C on health related quality of life. Dig Dis Sei 1997: 42: 2482-2486.
9. Foster G, Goldin R, Thomas H. Chronic hepatitis C virus infection causes a significant reduction in quality of life. Hepatology 1998: 27: 209-212.
10. Davis G, Baiart L, Schiff E, Lindsay K, Bodenheimer H, Perrillo R et al. Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 1994: 16: 334-343.
11. Schuling J, Greidanus J, Meyboom-de Jong B. Measuring func-tional status of stroke patients with the sickness impact profile. Disabil Rehabil 1993: 15: 19-23.
12. Bonkovsky HL, Wooley JM, The Consensus Interferon Study Group. Reduction of health related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999: 29: 264-270.
13. Carithers R, Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sei 1996: 41: 75S-80S.
14. Desmorat H. Quality of life during chronic hepatitis C: study of 466 patients before treatment. Hepatology 1998: 28(4): 472A.
15. Wollschlaeger S, Klauck S, Porst H. Assessment of quality of life in chronic hepatitis C. Hepatology 1998: 28(4): 203A.
16. Coughlan B, Sheehan J, Crowe J. HCV RNA status is not associated with psychological distress or psychiatric morbidity in a group of Irish women diagnosed with an iatrogenic hepatitis C infection. Hepatology 1998: 28(4): 472A.